Venmax Drugs and Pharmaceuticals share news, announcements and annual reports
BSE: 531015Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 28 Oct 2026. Previous close ₹14.00.
28 Oct: open ₹15.00, high ₹15.00, low ₹12.80
- Under BSE's graded surveillance, stage 0, on the list for 27 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15 Cr4,053rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Not shown: another business merged into the company on 30 Jun 2026, and the accounts this figure is made of do not include it yet. It returns once accounts of the company as it now is are filed. Price to book: how it is worked out
- Mergernew accounts awaited
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 15,688
Venmax Drugs and Pharmaceuticals has 398 announcements on record, routine notices left out; 2 in the 30 days to 29 Oct 2026, the latest on 26 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Venmax Drugs and Pharmaceuticals quarterly results
The board met on 7 Aug 2026 to consider quarterly results
Notice filed 3 Aug 2026
Venmax Drugs and Pharmaceuticals annual reports, presentations and earnings calls
The company's own documents, latest first.Venmax Drugs and Pharmaceuticals financials, year by year
Annual reports26
- Annual report, year to Mar 20261 Sep 2026
- Annual report, year to Mar 20252 Sep 2025
- Annual report, year to Mar 202423 Aug 2024
- Annual report, year to Mar 202317 Aug 2023
- Annual report, year to Mar 202216 Sep 2022
21 earlier reports
- Annual report, year to Mar 202116 Sep 2022
- Annual report, year to Mar 20206 Dec 2020
- Annual report, year to Mar 201921 Sep 2019
- Annual report, year to Mar 201812 Oct 2018
- Annual report, year to Mar 201711 Sep 2017
- Annual report, year to Mar 201617 Nov 2016
- Annual report, year to Mar 201516 Sep 2015
- Annual report, year to Mar 201411 Sep 2014
- Annual report, year to Mar 2013Filing day not known
- Annual report, year to Mar 2012Filing day not known
- Annual report, year to Mar 2011Filing day not known
- Annual report, year to Mar 2009Filing day not known
- Annual report, year to Mar 2008Filing day not known
- Annual report, year to Mar 2007Filing day not known
- Annual report, year to Mar 2006Filing day not known
- Annual report, year to Mar 2005Filing day not known
- Annual report, year to Mar 2004Filing day not known
- Annual report, year to Mar 2003Filing day not known
- Annual report, year to Mar 1999Filing day not known
- Annual report, year to Mar 1998Filing day not known
- Annual report, year to Mar 1997Filing day not known
Venmax Drugs and Pharmaceuticals merger and demerger filings
Filings about a merger, demerger or scheme of arrangement, latest first.
Filings2
- Update in respect of Scheme of Amalgamation of Hatri Pharma Private Limited (Amalgamating Company) with Venmax ....8 Sep 2026
- Approval of Modification of draft Scheme of Amalgamation submitted on November 12, 2025 between Hatri Pharma Private Limited (Transferor Company) and Venmax Drugs and Pharmaceuticals Limited ....27 Mar 2026
Venmax Drugs and Pharmaceuticals share news and announcements
Newest first. Page 1 of 8.
Oct 2026
Sep 2026
Aug 2026
24 Aug · Board meeting
Meeting on 31 Aug 2026: annual general meeting3 Aug · Board meeting
Meeting on 7 Aug 2026: quarterly results
Jul 2026
30 Jul · Announcement under Regulation 30 (LODR)-Allotment
29 Jul · Announcement under Regulation 30 (LODR)-Allotment
May 2026
6 May · Board meeting
Meeting on 14 May 2026: audited results
Apr 2026
6 Apr · Disclosure
Mar 2026
23 Mar · Announcement under Regulation 30 (LODR)-Allotment
Feb 2026
Jan 2026
30 Jan · Board meeting
Meeting on 7 Feb 2026: quarterly results21 Jan · Conversion Of Share Warrants Into Equity
Nov 2025
6 Nov · Board meeting
Meeting on 12 Nov 2025: quarterly results
Sep 2025
3 Sep · Board meeting
Aug 2025
25 Aug · Board meeting
Meeting on 2 Sep 2025: annual general meeting, amalgamation and increase in authorised capital8 Aug · Board meeting
Meeting on 16 Aug 2025
Jul 2025
23 Jul · Results
16 Jul · Board meeting
Meeting on 23 Jul 2025: quarterly results
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 1 Apr 2026Board or managers changedup 0.89%−1.1 pts vs Nifty 500market median 0.0% · five sessions +1.8% (−6.0 pts vs Nifty 500) · volume 0.0× usual · The announcement
- 12 Mar 2026Board or managers changedup 4.04%+4.7 pts vs Nifty 500market median 0.0% · five sessions −0.4% (+0.2 pts vs Nifty 500) · volume 0.0× usual · The announcement
- 25 Nov 2025Board or managers changed0.00%+0.1 pts vs Nifty 500market median 0.0% · five sessions +2.8% (+1.7 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 21 Apr 2025Board or managers changeddown 1.99%−3.5 pts vs Nifty 500market median 0.0% · five sessions −2.1% (−2.9 pts vs Nifty 500) · volume 0.5× usual · The announcement
- 27 Dec 2024Board or managers changedup 5.00%+4.9 pts vs Nifty 500market median 0.0% · five sessions +23.8% (+22.0 pts vs Nifty 500) · volume 0.4× usual · The announcement